Trial Profile
Clinical trial of the BioFreedom drug coated stent in Japanese patients with coronary artery disease and a high risk of bleeding.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 11 Feb 2015
Price :
$35
*
At a glance
- Drugs Umirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms LEADERS Free Japan
- Sponsors Biosensors International Group
- 11 Feb 2015 New trial record